D3 Pharma and Encap Drug Delivery are continuing partnership to advance the commercial manufacturing and product licensing program for Plenachol.
Plenachol is proprietary high-dose oral vitamin D3 product for the treatment of vitamin D deficiency and insufficiency.
The patented liquid-filled capsule formulation was developed in conjunction with Encap and is available at three dose-strengths 20,000, 40,000 and 100,000 international units.
Plenachol, which is free from animal derived excipients and peanut constituents, will continue to be made available as a Specials product during the pre-license phase through Encap.
Source:
http://drugdelivery.pharmaceutical-business-review.com/news/d3-pharma-encap-to-advance-plenachol-licensing-program-200612
